Latest news with #Ho
The Star
3 days ago
- General
- The Star
In calm or crisis, they're there
Rescue rangers: Search and Rescue Dogs Malaysia conducting one of their training sessions, while (below), the rescue dog will bark to alert its handlers, upon locating the victim — FAIHAN GHANI/The Star Search and rescue dogs can play pivotal role in saving lives PETALING JAYA: It has been a little over six months since Search and Rescue (SAR) Dogs Malaysia was recognised for its notable efforts. Since then, things have been relatively quiet – to its relief. 'There were no demands for our services during this period. "It's a rather good thing because that means no tragedies have happened,' said SAR Dogs Malaysia deputy president Wellington Ho. Despite the calm, there is no time to rest, he added. 'Weekly training still goes on. We cannot stop as we never know when disaster will strike. 'We have to be fully prepared on short notice. All our bags are packed and we're ready whenever needed,' said Ho in an interview. The team, which previously operated at three training sites, has also started working at two other locations – a plantation in Semenyih, and another in Kuala Kubu Baru, both in Selangor. Upon being named one of the Star Golden Hearts Award (SGHA) winners last year, Ho said the group received more attention from the public. As part of its expansion plans, he said the organisation's doors would always be open for new people to join. 'However, this also poses a challenge as our priority is to find the 'right' kind of people and dogs,' he said. Currently, Ho said the group has an additional four young dogs undergoing training to obtain International Rescue Organisation (IRO) certification, along with two new handlers. 'We hope for a positive outcome from this latest development. 'Whether or not they qualify as search and rescue dogs remains to be seen, as they have to go through a tough three-year training period,' he said, adding that those interested in joining could reach out through their social media page. Apart from the dogs undergoing training, SAR Dogs Malaysia has six handlers and two IRO-certified dogs at present. They are also associated with the Civil Defence Force. Ho added that financial expenses are among the other challenges they are facing. 'It can go up to the hundreds to maintain a working dog when it comes to food and medication. Unforeseen circumstances can also arise, which could see us forking out more,' he said. However, Ho remains optimistic, saying that they are always working to improve the group and their services. 'To aspiring changemakers, the most important thing is you must have passion. "Everything else such as expertise and skills can be developed but passion is foremost,' he said. The SGHA returns for the 11th edition to honour everyday Malaysians whose compassion and selflessness have made a lasting impact on others. With McDonald's Malaysia as its new strategic partner, SGHA is poised to broaden its reach and deepen its impact nationwide. This year also marks the debut of the McDonald's Caring Hearts Award – a special recognition honouring individuals or grassroots groups whose heartfelt acts of kindness have uplifted lives in profound and lasting ways. Since its inception in 2015, SGHA has honoured over 100 individuals and organisations whose efforts have inspired action, transformed lives and strengthened communities nationwide.
Business Wire
3 days ago
- Business
- Business Wire
Satellos Bioscience Shareholders Elect Two New Board Members
TORONTO--(BUSINESS WIRE)-- Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (' Satellos ' or the ' Company '), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced the election of Iris Loew-Friedrich, M.D., Ph.D., and Selwyn Ho, MBBS, to its Board of Directors. 'I am so excited to welcome Dr. Loew-Friedrich and Dr. Ho to our Board at this pivotal time,' said Frank Gleeson, Satellos co-founder and CEO. 'We believe their deep expertise in global clinical and commercial development will be invaluable to Satellos as we advance SAT-3247 and realize our technology's transformative potential for the treatment of people living with Duchenne muscular dystrophy and other degenerative conditions. We look forward to drawing on their proven expertise in positioning Satellos for future partnerships and development strategies focused on delivering optimal value for shareholders.' A highly accomplished biotech and pharmaceutical executive, Dr. Loew-Friedrich is recognized as the senior clinical leader who shaped UCB into a global powerhouse in neurology and immunology. Serving as executive vice president and chief medical officer until 2024, she led UCB's worldwide development and regulatory strategy for over two decades, overseeing the global approvals of multiple blockbuster therapies, including Cimzia, Briviact, Evenity, Rystiggo, Zilbrysq, and Bimzelx. Her leadership was instrumental in advancing both common and rare disease treatments, with a deep and sustained commitment to improving outcomes for underserved patient populations. Prior to UCB, Loew-Friedrich held senior R&D roles at Schwarz Pharma, BASF Pharma, and Hoechst/Aventis, where she contributed to the development and success of market-leading drugs such as Humira, Arava, Actonel, Vimpat, and Neupro. Dr. Ho is a seasoned pharmaceutical and biotech executive with broad leadership experience across commercial strategy, business development, financing, and board governance. He has held senior roles at global companies including Dermira (Eli Lilly), UCB, Allergan (AbbVie), Novartis, and AstraZeneca, with expertise spanning ophthalmology, immunology, oncology, and dermatology. As CEO of Medigene AG, he led a strategic transformation and established and extended key partnerships with BioNTech, Regeneron, WuXi Biologics and EpimAb Biotherapeutics. Previously, as EVP & chief business officer at Connect Biopharma, he was instrumental in raising over $350 million through IPO and private funding. He also serves on the boards of Antennova Inc. and Peptomyc S.L., and as executive-in-residence at New Rhein Healthcare Investors. As part of the Annual General Meeting, Rima Al-awar, Ph.D., William Jarosz, J.D., and William McVicar, Ph.D., did not stand for reelection. 'I want to personally thank Rima, Bill and Bill for their dedicated service, thoughtful leadership and support,' said Gleeson. 'Their guidance helped position Satellos for continued progress, and we wish them all the best in their future endeavors.' About Satellos Bioscience Inc. Satellos is a clinical-stage drug development company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases. Through its research, Satellos has developed SAT-3247, a first-of-its-kind, orally administered small molecule drug designed to address deficits in muscle repair and regeneration. SAT-3247 targets AAK1, a key protein that Satellos has identified as capable of replacing the signal normally provided by dystrophin in muscle stem cells to effect repair and regeneration. By restoring this missing dystrophin signal in DMD, SAT-3247 enables muscle stem cells to divide properly and more efficiently, promoting natural muscle repair and regeneration. SAT-3247 is currently in clinical development as a potential disease-modifying treatment initially for DMD. Satellos also is leveraging its proprietary discovery platform MyoReGenX™ to identify additional muscle diseases or injury conditions where restoring muscle repair and regeneration may have therapeutic benefit and represent future clinical development opportunities. For more information, visit Notice on Forward-Looking Statements This press release includes forward-looking information or forward-looking statements within the meaning of applicable securities laws regarding Satellos and its business, which may include, but are not limited to, statements regarding the potential for SAT-3247 to represent a disease modifying approach to the therapeutic treatment of people living with Duchenne; anticipated benefits to patients from a small molecule treatment for Duchenne; the advancement SAT-3247 through clinical trials; the pharmacodynamic properties and mechanism-of-action of SAT-3247; the potential of our approach in other degenerative muscle diseases; its/their prospective impact on Duchenne patients, patients with other degenerative muscle disease or muscle injury or trauma, and on muscle regeneration generally; and Satellos' technologies and drug development plans. All statements that are, or information which is, not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, occurrences or developments, are 'forward-looking information or statements.' Often but not always, forward-looking information or statements can be identified by the use of words such as 'shall', 'intends', 'believe', 'plan', 'expect', 'intend', 'estimate', 'anticipate', 'potential', 'prospective' , 'assert' or any variations (including negative or plural variations) of such words and phrases, or state that certain actions, events or results 'may', 'might', 'can', 'could', 'would' or 'will' be taken, occur, lead to, result in, or, be achieved. Such statements are based on the current expectations and views of future events of the management of the Company. They are based on assumptions and subject to risks and uncertainties. Although management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including, without limitation, risks relating to the pharmaceutical and bioscience industry (including the risks associated with preclinical and clinical trials and regulatory approvals), and the research and development of therapeutics, the results of preclinical and clinical trials, general market conditions and equity markets, economic factors and management's ability to manage and to operate the business of the Company generally, including inflation and the costs of operating a biopharma business, and those risks listed in the 'Risk Factors' section of Satellos' Annual Information Form dated March 26, 2025 (which is located on Satellos' profile at Although Satellos has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Satellos does not undertake any obligation to publicly update or revise any forward-looking statement, whether resulting from new information, future events, or otherwise. 530509798v.1
South China Morning Post
4 days ago
- Climate
- South China Morning Post
Hong Kong hiker, 69, dies after collapsing on Wilson Trail
A 69-year-old hiker has died after collapsing on Hong Kong's Wilson Trail in Tsz Wan Shan. Advertisement The man, surnamed Ho, was found lying unconscious by hikers at around 9.13am on Wednesday on Section 5 of the trail. According to police, paramedics found Ho unresponsive. The Government Flying Service then dispatched a helicopter to airlift him to Pamela Youde Nethersole Eastern Hospital, where he was pronounced dead at 10.59am despite resuscitation efforts. Temperatures on Wednesday ranged between 28 and 32 degrees Celsius (82.4 and 86.9 Fahrenheit), accompanied by high humidity levels between 70 and 90 per cent. The weather is mainly cloudy with isolated showers, as well as hot and sunny intervals in the afternoon. The about 8km long Wilson Trail Section 5 begins at Lion Pavilion on Sha Tin Pass Road, between Lion Rock and Tsz Wan Shan. The trail first passes through Shap Yi Wat and then connects to the aqueduct of Beacon Hill before ending at the Tai Po Road exit. Advertisement
Business Insider
4 days ago
- Business
- Business Insider
Desjardins Remains a Buy on AGF Management B NV (AGF.B)
In a report released today, Gary Ho from Desjardins maintained a Buy rating on AGF Management B NV (AGF.B – Research Report), with a price target of C$14.00. The company's shares closed today at C$12.07. Confident Investing Starts Here: Ho covers the Financial sector, focusing on stocks such as AGF Management B NV, Alaris Royalty, and Dominion Lending Centres, Inc. (Canada) Class A. According to TipRanks, Ho has an average return of 10.8% and a 60.53% success rate on recommended stocks. Currently, the analyst consensus on AGF Management B NV is a Strong Buy with an average price target of C$12.75. Based on AGF Management B NV's latest earnings release for the quarter ending February 28, the company reported a quarterly revenue of C$136.93 million and a net profit of C$30.95 million. In comparison, last year the company earned a revenue of C$113.4 million and had a net profit of C$30.55 million Based on the recent corporate insider activity of 41 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AGF.B in relation to earlier this year.
RTHK
4 days ago
- Politics
- RTHK
8,700 rental flats resumed in John Lee's term so far
8,700 rental flats resumed in John Lee's term so far Winnie Ho says the 8,700 flats that have been taken back shows the administration's determination to combat tenancy abuse. Photo: RTHK Secretary for Housing Winnie Ho said the government is following up on around 700 reports of tenancy abuse since the Report Public Housing Abuse Award scheme was rolled out in January. Under the scheme, those who bring an instance of illegal public housing use to light can earn up to HK$3,000 and get a certificate of appreciation if the information helps authorities take back the flat. Speaking to RTHK to mark the third year of Chief Executive John Lee's administration as well as the 28th anniversary of the SAR's establishment, Ho said 3,900 reports of public rental housing abuses have been received so far. Of the 1,700 cases that the authorities have looked into in detail, about 700 were found to be more useful. "Looking ahead, I hope that we will be able to hand out the first batch of rewards, perhaps by the middle of the year around the summer holidays," Ho said. "Some residents will get this report public housing abuse award, and each of them will get HK$3,000. "We will respect the winners' wishes on how they want to find out if they've won, and whether they want to take the certificate or cheque in person or would like us to mail it to them. "We will try to act in accordance with their wishes." Ho told RTHK that as of the end of May, the government had taken back 8,700 flats since the current-term administration assumed office. These cases include tenants who had leased their flats online for up to HK$6,000 or turned them into a gym business, she said. The number of flats that had been resumed showed the government's execution capabilities and determination in combating tenancy abuses. The housing chief went on to say that the city's first light public housing project at Yau Pok Road in Yuen Long is almost fully occupied. The site, which offers about 2,150 units, has seen tenants moving in since March in batches. "I have already handed out more than 2,100 keys, some of them have moved in, while others are arranging a move," Ho said. "I believe it will be fully occupied in no time." Ho said the first batch of tenants at another similar project on Choi Hing Road in Ngau Tau Kok would be able to start moving in at the end of June. The project is another first-phase light public housing project and has around 2,290 units. Looking ahead, Ho said the government will look into various ways to save on construction cost for public housing projects in the future, such as adopting direct purchases for structures built using modular integrated construction method.
